Taiho Ventures Boosts Investment Pool to $400M for Enhanced Open Innovationby Lilu Anderson 08.01.2024Taiho Ventures increases investment pool to $400M, reinforcing commitment to supporting innovative biotech start-ups in drug discovery. #Taiho #biotech #innovation
AuditOne Closes €800K Seed Funding Round: A Boost for Future Growthby John Darbie 08.01.2024AuditOne, a Cologne-based provider of a smart contract security platform, has raised €800K in Seed funding to drive the development ...
The Muted Evolution of AI Investmentby John Darbie 07.01.2024Is the global economy ready for the transformative potential of generative AI? Current trends suggest a lack of significant investment.
Hansa Biopharma’s Strong Q4: SEK 50m Revenueby Mark Eisenberg 06.01.2024Hansa Biopharma reports Q4 revenue growth and expansion into new markets, with impressive results and increasing demand for their therapeutic ...
CRISPR QC’s Series A Round Secures Funding from Xcellerant Venturesby John Darbie 05.01.2024San Diego-based CRISPR QC secures Series A funding from Xcellerant Ventures, driving further developments in its CRISPR Analytics Platform.
Global VC Deals Reach New High on January 5th, 2024by Mark Eisenberg 05.01.2024OnCusp Therapeutics raises $100M in Series A funding to advance its research and development efforts in innovative therapeutics. #biotech #funding
Exploring Biotech ETFs: Investing in Medical Breakthroughsby Mark Eisenberg 05.01.2024Biotech ETFs offer investors a way to access the potential gains of the biotech industry. From breakthrough medicines to innovative ...
The Elusive World of Redirects: How They Impact Usersby Lilu Anderson 04.01.2024The impact of climate change on global agriculture is posing a significant threat to food security and requires innovative solutions ...
Leveraging SWOT Analysis for Business Successby John Darbie 03.01.2024SWOT analysis is a powerful tool that helps businesses assess their strengths, weaknesses, opportunities, and threats to make informed decisions. ...
Goldman Sachs Establishes $650M Fund for Biotech Innovationby Mark Eisenberg 03.01.2024Goldman Sachs Asset Management launches a $650M life sciences fund, focusing on growth-oriented private equity investments in early- to mid-stage ...